271 related articles for article (PubMed ID: 8381766)
1. The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis.
Raju U; Zarbo RJ; Kubus J; Schultz DS
Hum Pathol; 1993 Feb; 24(2):173-81. PubMed ID: 8381766
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
3. DNA analysis of ductal carcinoma in situ of the breast. A comparison with histologic features.
Killeen JL; Namiki H
Cancer; 1991 Dec; 68(12):2602-7. PubMed ID: 1657363
[TBL] [Abstract][Full Text] [Related]
4. Value of cytometric analysis for distinction of intraductal carcinoma of the breast.
Fisher ER; Siderits R
Breast Cancer Res Treat; 1992; 21(3):165-72. PubMed ID: 1325216
[TBL] [Abstract][Full Text] [Related]
5. The Histologic Spectrum of Apocrine Lesions of the Breast.
Durham JR; Fechner RE
Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
[TBL] [Abstract][Full Text] [Related]
6. Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast.
Carpenter R; Gibbs N; Matthews J; Cooke T
Br J Surg; 1987 Oct; 74(10):905-6. PubMed ID: 2822199
[TBL] [Abstract][Full Text] [Related]
7. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
Goldstein NS; O'Malley BA
Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
Yang G; Guo L; Jin H; Li J; Ding H
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
[TBL] [Abstract][Full Text] [Related]
9. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
[TBL] [Abstract][Full Text] [Related]
10. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
11. Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma.
Niu Y; Wang S; Liu T; Zhang T; Wei X; Wang Y; Jiang L
Pathol Res Pract; 2013 Apr; 209(4):221-7. PubMed ID: 23523041
[TBL] [Abstract][Full Text] [Related]
12. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
13. Utility of four-quadrant random sections in mastectomy specimens.
Gupta D; Nath M; Layfield LJ
Breast J; 2003; 9(4):307-11. PubMed ID: 12846866
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
[TBL] [Abstract][Full Text] [Related]
15. Nuclear chromatin characteristics of breast solid pattern ductal carcinoma in situ.
Frank DH; Davis JR; Alberts DS; Thompson D; Liu Y; Bartels PH
Anal Quant Cytol Histol; 2001 Dec; 23(6):418-26. PubMed ID: 11777277
[TBL] [Abstract][Full Text] [Related]
16. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of apocrine lesions of the breast.
O'Malley FP; Bane AL
Adv Anat Pathol; 2004 Jan; 11(1):1-9. PubMed ID: 14676636
[TBL] [Abstract][Full Text] [Related]
18. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
19. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
D'Arcy C; Quinn C
J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ of the breast: a comparative analysis of histology, nuclear area, ploidy, and neovascularization provides differentiation between low- and high-grade tumors.
Ruiz A; Almenar S; Cerdá M; Hidalgo JJ; Puchades A; Llombart-Bosch A
Breast J; 2002; 8(3):139-44. PubMed ID: 12047469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
